Details.
Professional support for investors across the life sciences and healthcare sectors, including biopharma, diagnostics, biopharma services such as CROs, CDMOs, and CCOs, and life science tools. Services combine industry expertise and data-driven analysis to support buy-side and sell-side engagements throughout the investment lifecycle, from target identification and due diligence to portfolio company strategy development and exit planning.